Pulmonary vasodilatory action of endogenous atrial natriuretic factor in rats with hypoxic pulmonary hypertension. Effects of monoclonal atrial natriuretic factor antibody.
Authors:
- 1 January 1992
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 70 (1) , 184-192
Abstract
We administered ascitic fluid containing atrial natriuretic factor (ANF) monoclonal antibody to rats after 3 weeks of exposure to hypoxia while the rats were still hypoxic. In additional chronically hypoxic rats, we infused synthetic rat ANF. In conscious chronically instrumented rats, after a bolus dose of 5 micrograms i.v. ANF, pulmonary arterial pressure fell significantly from 26.5 +/- 2 to 21 +/- 2 mm Hg (p less than 0.01), reaching its nadir at 5 minutes without change of systemic arterial pressure, cardiac output, or heart rate. Pulmonary arterial pressure increased gradually from 26 +/- 4 to 34 +/- 4 mm Hg within 30 minutes (p less than 0.05) after acute administration of ANF monoclonal antibody and decreased transiently to return to baseline within 15 minutes after infusion of control ascitic fluid containing monoclonal antibody against an apolipoprotein. Cardiac output and heart rate remained unchanged after both ANF monoclonal antibody and control ascitic fluid. In normoxic rats, acute administration of ANF monoclonal antibody did not cause significant changes in pulmonary arterial pressure, cardiac output, or heart rate. Rats receiving weekly intravenous injections of ANF monoclonal antibody that were started before initiation of exposure to hypoxia experienced significantly aggravated pulmonary hypertension and right ventricular hypertrophy compared with rats receiving repeated infusions of control ascitic fluid. However, there was no significant difference in small pulmonary arterial wall thickness or percentage of muscularized arteries at the alveolar duct level. These results suggest that endogenous ANF attenuates hypoxic pulmonary hypertension by decreasing pulmonary vascular tone.Keywords
This publication has 20 references indexed in Scilit:
- Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia.Journal of Clinical Investigation, 1991
- Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.Journal of Clinical Investigation, 1990
- Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.Journal of Clinical Investigation, 1990
- Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.Journal of Clinical Investigation, 1989
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion.Journal of Clinical Investigation, 1989
- A murine monoclonal antibody against rat atrial natriuretic factor (ANF) which cross-reacts with mouse ANFMolecular Immunology, 1987
- Specific receptors for atriopeptin III in rabbit lungBiochemical and Biophysical Research Communications, 1986
- The Renal Response to Acute Hypervolemia is Caused by Atrial Natriuretic PeptidesJournal of Cardiovascular Pharmacology, 1986
- Characterization of monoclonal antibodies against human low density lipoprotein.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983